Dr. Yaodong Huang, PhD joins ACME Bioscience, a Frontage Laboratories Inc company with over 15 years of experience in medicinal chemistry and organic synthesis. He had previously worked for ACME… Read More
Frontage Laboratories, Inc. announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera)…. Read More
VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, announced that Maureen O’Connell has stepped down from her position as Director and Audit… Read More
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. – United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will provide… Read More
Proceeds expected to extend cash runway into H2 2027 VANCOUVER, BC – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biopharmaceutical company developing novel, multifunctional biotherapeutics, announced that it had entered into… Read More
